Dr. Justin Harper and Sam Peck Selected For Allergan Medical Spa Advisory Board

Friday, November 9, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

The Founder of Juvly Aesthetics, Dr. Justin Harper and Sam Peck, the Director of Operations and Business Development, have been selected for Allergan's Medical Spa Advisory Board for 2018.

NEW YORK, Nov. 09, 2018 /PRNewswire-PRWeb/ -- The Founder of Juvly Aesthetics, Dr. Justin Harper

and Sam Peck, the Director of Operations and Business Development, have been selected for Allergan's Medical Spa Advisory Board for 2018.

Juvly Aesthetics will be celebrating its 4 year anniversary on Wednesday, November 14th. Dr. Harper and the Juvly team are proud to have grown this small start-up business from 1 to 11 locations in 4 years. Juvly is one of the fastest growing and top rated medical spas in the country.

Juvly specializes in non-surgical aesthetic procedures including Allergan's portfolio of injectable products. In addition, Juvly offers anti-aging laser procedures and non-surgical fat reduction with Coolsculpting.

Out of roughly 18,000 practices in the United States that are actively purchasing Botox Cosmetic, Juvly is #5 by volume. Sam Peck and Dr. Harper stated, "We consider ourselves fortunate to be selected to attend the Allergan Medical Spa Advisory Board. Having the opportunity to provide input that can potentially shape the business practices of a company like Allergan, a leader in the facial aesthetics industry, is especially humbling. We look forward to discussing the current and future trends of the aesthetics industry and helping to shape the future of aesthetics in the United States."

Allergan plc is a global pharmaceutical company. The Allergan portfolio of brands includes Botox®, Juvederm®, Juvederm Voluma®, Kybella®, Juvederm Volbella®, Latisse® and SkinMedica®. Allergan also recently acquired Zeltiq, the makers of Coolsculpting®.

 

SOURCE Dragonfly



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store